Identity and synonyms
Identity follows the supplied name and synonyms; no additional identity description is supplied.
Synonyms: KP-10 · Kisspetin-10 (source spelling)
Peptide or peptide-related · Peptide or peptide derivative
Detailed molecular class: Peptide
Supplied sequence or chemical reference
See identity note; no supplier sequence accepted as verification.
Mechanism
KISS1R agonism in reproductive/metabolic research.
Evidence and critical reading
Reported scientific and empirical uses
Fertility and reproduction · Sexual function
Offered for gonadal-axis/fertility use; residue number must remain in the identity.
Human evidence
Registered human physiological studies; do not assign kisspeptin-54 HSDD results to KP-10.
Preclinical evidence
Shared receptor does not establish equivalent exposure.
Critical reading and limitations
Do not transfer kisspeptin-54 results or dosing from chapters labeled only “kisspeptin”.
Evidence applies to the exact molecule, formulation, route, population and endpoint studied. Supplier identity, purity and clinical equivalence are unverified.
Source-specific regimens
Descriptive source observations, not individual recommendations.
Regulatory product labeling
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Human-study exposure
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Empirical handbook
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Regulation and safety
Jurisdiction-specific regulatory context
Jurisdiction-specific approval not verified in this card; do not infer global nonapproval.
Adverse effects and unknowns
FDA notes limited route-specific safety and immunogenicity uncertainty.
Product characterization and route-specific safety are limited; do not assume no hormonal interactions.
Contraindications
See supported safety statements and exact product label; a complete contraindication set has not been established for this catalog material.
A complete list must match the exact authorized product. For experimental materials without verified human labeling, a complete contraindication set is not established here. No list does not mean safety.
Interactions
Only explicitly cited interactions may be asserted; unstudied combinations remain unknown, not interaction-free.
Separate documented interaction, pharmacologic plausibility and unknown interaction. Absence of a blend trial does not establish compatibility.
Studies and trials
Selected studies
No selected studies are attributed in this record.
Trials attributed in the package
NCT03771326 · KP-10 and Insulin Secretion in MenRegistry status: CompletedLast update posted: December 12, 2018Query verification: October 16, 2026
Trial registration does not establish efficacy or validate commercial material.
Query candidates; attribution pending
Kisspeptin-10 · 5 unfiltered query results, not authenticated trials
Query verification: October 16, 2026
Exact phrase intervention query; first three most recently updated records, not exhaustive. Aliases may be missed and heterogeneous products may appear. The total is the unfiltered registry query count, not authenticated trials. Source-integrity holds are excluded from ordinary listings.
View trial registry queryNCT05456854 · Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic ClampRegistry status: WithdrawnLast update posted: August 14, 2024Query verification: October 16, 2026
NCT04532801 · Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal ToleranceRegistry status: WithdrawnLast update posted: August 1, 2024Query verification: October 16, 2026
NCT03771326 · KP-10 and Insulin Secretion in MenRegistry status: CompletedLast update posted: December 12, 2018Query verification: October 16, 2026
Source issues and references
The Kisspeptin chapter presents a long sequence; do not automatically assign its regimen to the marketed kisspeptin-10 decapeptide. · manual01 · Page 64
References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.
- R06
- manual01
Peptide Handbook — James B. LaValle, Gordon Crozier, Joseph P. Cleaver and Andrew Heyman
James B. LaValle; Gordon Crozier; Joseph P. Cleaver; Andrew Heyman
October 16, 2026
Bibliographic attribution only. The supplied handbook is a secondary empirical practice source, not clinical verification. Private source files and supplier/download destinations are not provided here.
- pdf01
PEPNEXA 2.pdf
October 16, 2026
- pdf02
ELLA PEPTIDES.pdf
October 16, 2026
- pdf03
zlz list 26.8.5.pdf
October 16, 2026
- pdf05
PEPNEXA.pdf
October 16, 2026
- pdf07
US Peptide MangerCorp(1).pdf
October 16, 2026
- pdf09
PeptideFactory.pdf
October 16, 2026